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ABSTRACT
Background: Each year, approximately 350 000
women in the UK experience perineal suturing
following childbirth. For those women whose perineal
wound dehisces, the management will vary according
to individual practitioner’s preferences. For most
women, the wound will be managed expectantly
(healing by secondary intention), whereas others may
be offered resuturing. However, there is limited
scientific evidence and no clear guidelines to inform
best practice. PREVIEW is a two-part study aiming to
identify the best management strategy for dehisced
perineal wounds, in terms of clinical effectiveness and
women’s preferences.
Methods/design: The main part of this study is
a pilot and feasibility randomised controlled trial
designed to provide preliminary evidence of the
effectiveness of resuturing versus expectant
management for dehisced perineal wounds following
childbirth and to feed into the design and feasibility of
a larger definitive trial. 144 participants will be
randomly allocated to either intervention. The primary
outcome is the proportion of women with a healed
perineal wound at 6e8 weeks from the trial entry.
Secondary outcomes include perineal pain, breast
feeding rates, dyspareunia and women’s satisfaction
with the aesthetic results of the wound healing at 6
weeks, 3 months and 6 months post randomisation.
Information will be collected using validated
questionnaires. The second part of this study will be
to conduct semistructured interviews with 12 study
participants, aiming to capture information relating to
their physical and psychological experiences
following perineal wound dehiscence, assess the
acceptability of the research plan and ensure that all
outcomes relevant to women are included in the
definitive trial.
Dissemination: The results of this study will inform
a definitive randomised controlled trial that will provide
conclusive evidence of what is the best management of
perineal wound dehiscence. This will potentially lead to
significant improvements in perineal care and will help
to reduce the short- and long-term morbidity
experienced by women.
Clinical trials registration: PREVIEW is registered
with the International Standard Research for Clinical
Trials (no: ISRCTN05754020) and adopted as
a National Institute for Health Research (NIHR)
Reproductive Health and Childbirth specialty group
portfolio study UKCRN ID 9098.
INTRODUCTION
Perineal trauma affects a vast amount of
women both nationally and internationally
with more than 350 000 women in the UK per
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ARTICLE SUMMARY
Article focus
- This article provides the rationale and protocol
for a pilot and feasibility randomised controlled
trial, designed to provide preliminary evidence of
the effectiveness of resuturing of dehisced
perineal wounds, versus healing by expectancy
(secondary intention) and to feed into the design
and feasibility of a larger definitive trial.
Key messages
- This study addresses an area of clinical research
that has been extremely neglected and has the
potential of making a significant impact on
women’s health and well-being.
Strengths and limitations of this study
- As both a pilot randomised controlled trial and
a feasibility study, this research will test out
many of the procedures that will be used to
inform the design of a definitive trial.
- As the definitive trial is likely to require many
centres in order to meet sample size require-
ments, we may use this pilot to identify additional
sites and also test out study procedures in those
sites. Thus, the actual sample size might be
larger than described here.
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year needing stitches to facilitate healing of a sponta-
neous tear or episiotomy.1 Given that the postpartum
management of perineal trauma including the preven-
tion of wound infection and assessing wound healing are
core components of routine maternity care,2 3 there is
limited research evidence available on the management
and consequences of wound dehiscence. Furthermore,
the available evidence is based on retrospective audit or
case reviews and tends to include small numbers of
participants hence is subject to bias. Anecdotal evidence
suggests that the number of women reporting perineal
infections and dehiscence in the community is
increasing; however, systems to track these complications
following hospital discharge are lacking. It is vital that
a true estimate of the problem is established using
standardised definitions of wound infection and at the
same time determine best practice when treating
dehisced perineal wounds. It is apparent that perineal
wound dehiscence both locally and worldwide has not
been a high priority either in practice or in research, and
therefore, management is not based on robust evidence.
Due to the lack of evidence-based guidelines, clinical
practice varies widely between individual practitioners
and institutions.
Perineal wound dehiscence, which is commonly
reported to be associated with infection,4 5 may lead to
major physical, psychological and social problems if left
untreated. Although maternal mortality associated with
perineal trauma is extremely rare in developed coun-
tries, an infected perineal wound is a potential route for
systemic infection whereby sepsis and septic shock may
ensue.6 Indeed sepsis has for the first time been identi-
fied as the leading cause of maternal mortality in the UK.
The Centre for Maternal and Child Enquiries recently
published their eighth Report on Confidential Enquiries
into Maternal Deaths.7 The report revealed that during
the 2006e2008 triennium, sepsis resulted in 26 direct
maternal deaths with three further deaths classified as
‘Late Direct Deaths’ (occurring more than 6 weeks after
delivery). Seven women died of sepsis following a vaginal
delivery, including one woman with an infected peri-
neum following a second-degree tear. The report clearly
illustrates how healthy women with an uncomplicated
pregnancy and delivery can become critically ill and die
in a very short time.7
Moreover, morbidity associated with perineal wound
dehiscence can and does pose a serious threat to the
general well-being and quality of life of the new mother.
Maternal morbidity centres around persistent pain and
discomfort at the perineal wound site, urinary retention,
defecation problems, dyspareunia and psychological and
psychosexual issues from embarrassment and altered
body image.2 8 Furthermore, the relationship with her
newborn baby may become affected, and she may find
difficulty in breast feeding due to the distress caused by
her perineal problems.9
Perineal wound infection and dehiscence is a burden
on NHS resources, as quite often women who suffer this
consequence of childbirth, have to undergo corrective
surgery, perineal refashioning and excision of excessive
scar tissue or other procedures associated with the
management of perineal dysfunction.10
Members of our collaborative team conducted double
iteration Delphi surveys in the UK and Brazil to identify
childbirth-related perineal trauma outcomes deemed to
be important by women.11 These surveys consistently
demonstrated that the highest ranked outcome was fear
of perineal wound infection and delay in wound healing.
Indeed, an outcome that appears to be prioritised by
women across different backgrounds and cultures.
Rationale for PREVIEW
This study addresses an area of clinical research that has
been extremely neglected and has the potential of
making a significant impact on women’s health and well-
being. For those who suffer from dehisced perineal
wounds, it can take up to 16 weeks to heal if treated
expectantly and can leave the new mother feeling very
traumatised. Some of these women may even request
that the mode of delivery for subsequent pregnancies
will be via caesarean section to avoid further perineal
damage.
Currently, lack of established professionally agreed
standards leave clinicians in equipoise as to what is the
best management for dehisced perineal wounds
following childbirth, hence supporting the need for
a clinical trial to answer this question. As both a pilot
randomised controlled trial (RCT) and a feasibility
study, this research will test out many of the procedures
that will be used to inform the design of a definitive trial.
Although this is a pilot trial, the sample size is reasonably
high (n¼144), and in the absence of definitive trials, will
contribute to the development of evidence-based best
practice guidelines by policymakers, clinicians, patients
and the public to develop, and to systematic reviews.
METHODS/DESIGN
Study design
PREVIEW is a pilot and feasibility RCT comparing
resuturing versus expectant management for the treat-
ment of dehisced perineal wounds following childbirth
(figure 1).
The study will provide researchers with a unique
opportunity to identify and prepare for the challenges
and uncertainties of evaluating the clinical interventions
within a larger RCT. Conducting this study will assess the
acceptability of the study interventions to women, test the
study protocol and facilitate a formal sample size calcu-
lation for the definitive study. Ultimately, it will enhance
the scientific rigour and value of the full-scale study.
Setting
The pilot and feasibility RCTwill be conducted in several
maternity centres in the UK in order to assess likely
recruitment rates and acceptability across different sites.
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Study population, eligibility criteria
Women, who had a primary repair of a second-degree
perineal tear or episiotomy, identified with a dehisced
wound within 2 weeks following childbirth, in any of the
recruiting sites.
For the purpose of the study, wound dehiscence is
defined as separation of both the skin and muscle layers.
Exclusion criteria
< No valid written consent to participate in the study
< poor pregnancy outcome (women experiencing
a pregnancy loss in current pregnancy)
< women younger than 16 years
< women who are considered by the anaesthetist to
have an unacceptable anaesthetic, for example,
complex cardiac anomalies
< due to financial constraints in relation to translation
services, women who do not understand, read or write
the English language will not be able to participate.
However, a record of the number of these potential
participants and their first language will be kept to
help with project planning and resource allocation
for the definitive study.
Consent and randomisation
Women eligible for the study will be provided with the
study information leaflet, by their community midwife,
hospital midwife or obstetrician and they will be allowed
time to ensure that they understand the information and
clarify any queries they have. Women who subsequently
do not wish to participate in the PREVIEW study will be
managed in accordance with local hospital guidelines.
Women will be enrolled into the study by a midwife or
doctor who is fully aware of Good Clinical Practice
guidance. A valid written consent will be obtained from
women who wish to participate. The PREVIEW Study
integrated web- or telephone-based randomisation, and
its treatment allocation service was developed by the
Bristol Randomisation Trials Collaboration. The alloca-
tion ratio will be 1:1, and randomisation will be in
blocks, stratified by study centre. The study participants
will be assigned to either resuturing of the dehisced
perineal wound preferably within 48 h of randomisation
or expectant management (allowing the wound to heal
by secondary intention). With the woman’s agreement,
a letter will be sent to her general practitioner
confirming trial entry.
Interventions
Secondary resuturing is being compared with expec-
tancy (healing by secondary intention). Both interven-
tions will be undertaken following trial standardised
procedures (not submitted but available from the trial
team).
To ensure the standardisation of secondary resuturing,
the trial team have provided recommendations for both
the methods and materials to be used (table 1). These
recommendations are based on clinical expertise and
knowledge and will be continually reviewed if new
evidence becomes available.
Due to the nature of the interventions, it will not be
possible to blind outcome assessors, care providers or
participants themselves. Assessment of perineal wounds
following treatment allocation, at the agreed time
periods, will be undertaken by independent practi-
tioners (ie, not part of the research team); however, it
will not be possible to blind participating women, oper-
ators and assessors due to the nature of the intervention.
Women allocated to the control arm will receive expec-
tant management (current standard intervention), with
no additional concomitant care or interventions.
Data collection
Standardised PREVIEW questionnaires are based on
those used and tested by members of the research team
Figure 1 PREVIEW flowchart.
Table 1 Methods and materials for resuturing
Methods Standard surgical procedures for secondary suturing should be followed, including wound
debridement if needed
Vaginal mucosa Continuous technique
Muscle Interrupted sutures
Skin Depending on the length of the wound, the skin could be sutured by interrupted or subcutaneous
sutures or left unsutured if the edges are approximated by suturing the underlying tissues
Materials To ensure standardisation of materials, the PREVIEW Study team recommend that standard
synthetic polyglactin 910 (gauge 2/0) suture material should be used as the material of choice
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in other childbirth-related perineal trauma studies.12 13
Participating women for the RCT will be reviewed at 2
and 6e8 weeks. The independent assessor will complete
a perineal assessment questionnaire at each visit. For the
secondary outcomes, all participating women in the RCT
will be asked to complete a prepaid postal questionnaire
at 6 weeks, 3 and 6 months following trial entry,
respectively.
Data will be scanned into a bespoke database by the
Market Research Group at Bournemouth University. By
anonymising records and changing treatment allocation
to a numeric code, the completed database will be
supplied to the research team for analysis, carried out
under the supervision of the trial statistician. In this way,
analysis will be blinded.
In addition to the pilot RCT, a sample of women
(n¼12) who are participating in the RCT will be selected
to represent age, parity, ethnicity and intervention.
Indepth semistructured interviews will be conducted
with written consent to capture information relating to
their physical and psychological experiences following
perineal wound dehiscence at 6e8 weeks following birth.
The interviews will be taped, with permission, and
transcribed.
Study outcome measures
Primary outcomes
< Proportion of women with a healed wound at
6e8 weeks following trial entry.
Secondary outcomes
< Pain at 6 weeks, 3 and 6 months following trial entry
(randomisation)
< Dyspareunia at 6 weeks, 3 and 6 months following
trial entry
< rates of breast feeding at 6 weeks, 3 and 6 months
following trial entry
< woman’s satisfaction with the aesthetic results of the
perineal wound at 6 weeks, 3 and 6 months following
trial entry.
Withdrawal from the PREVIEW Study
Participants may withdraw from the study at any time.
Should they choose to withdraw, they will continue
to be followed up, in line with current practice
within the participating unit, but no further question-
naires will be sent. One reminder questionnaire will be
issued to non-responders before they are deemed to
have withdrawn. A record of the number of withdrawals
will be kept and if applicable their reason for with-
drawal.
Statistical issues
Sample size for the RCT
The current literature does not support a robust formal
sample size calculation for the primary outcome of
interest. One of the purposes of this pilot study is to
collect data to inform a sample size calculation for
a full-scale RCT. Three aspects of informing this calcu-
lation are to estimate (1) the recruitment rate, (2)
attrition rate and (3) the proportion of women whose
wound had healed at 6e8 weeks (the primary
outcome). Hence, in estimating the sample size of this
pilot study, we attempted to ensure a sufficient degree
of precision of these estimates (precision defined as
twice the SE).
A retrospective study at the host research site has
identified that there were 117 women referred to the
perineal care clinic with a dehisced perineal wound
during a 4-year period (30 women/year). Hence, we
estimate that there will be around 45 eligible women for
recruitment per participating centre. Assuming that 45
women will be eligible per centre, with a take up rate of
80% and an attrition rate of 20% in four participating
centres, we expect to recruit 144 women and 116 (58 in
each arm) of these to complete the pilot study. This
would allow for the recruitment rate in each site to be
estimated with precision of 612% (based on n¼45),
and overall recruitment rate to be estimated with
precision 66% (based on n¼180). Loss to follow-up
would be estimated with precision 67% (based on
n¼144), and healing at 6e8 weeks (assumed to be
around 50% from the retrospective study mentioned
above) would be estimated to 613% in each trial arm
(based on n¼58 per arm). Although the sample size is
quite large for a pilot study, we feel that this is necessary
in order for recruitment to start bedding down in each
of multiple sites.
Estimating effect size is not a specific aim of this pilot,
but nevertheless, it is still worth considering precision
and power issues given the sample size of 116. Assuming
that healing in the secondary intention group will be
50% at 6e8 weeks and that realistic percentages in the
secondary resuturing group will be between 10% and
90%, the effect size for the primary outcome will be
estimated with a precision of between 615% and 618%.
This will be fed into deliberations regarding plausible
effect sizes to be used for future sample size calculations.
It is worth noting that with this sample size, the study will
have 90% power to detect an increase in healing from
50% to 80% (assuming a 5% two-sided significance
level).
As the definitive trial is likely to require many centres
in order to meet sample size requirements, we may use
this pilot to identify additional sites and also test out
study procedures in those sites. Thus, the actual sample
size might be larger than described here.
Statistical analysis for the RCT
Recruitment and attrition rates (overall and at each site)
and proportion with healed wound at 6e8 weeks will be
calculated, and precision of these estimates expressed
using 95% CIs. A series of sample size calculations for
a definitive RCT will be performed incorporating these
interval estimates.
A statistical analysis plan for a full-scale RCT will be
developed from and tested upon the data from this pilot
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study. We will test out the practicalities of ensuring that
the person analysing the data is blinded to group
allocation.
Primary analysis will be undertaken on an intention-to-
treat basis to limit the possibility of bias associated with
women not receiving the intervention they were allo-
cated. Strategies will be developed to ensure that data on
primary outcome are as complete as possible
(eg, reminder letters and phone calls).
Comparisons will be made between the interventions
(secondary repair vs expectant management). Baseline
characteristics of the comparative groups will be
summarised using standard descriptive statistics. The
primary outcome is the proportion of wounds healed at
6e8 weeks; this will be compared between the two
groups using a logistic regression model that incorpo-
rates study site as a variable (since randomisation was
stratified by site). Precision of estimates of effect size
(ORs) will be summarised using 95% CIs. The analysis
plan for other outcomes will also be developed taking
into account the type and distribution of data
(eg, logistic regression, multiple regression). If the
amount of missing data seems problematic (eg, over
20%), we will assess the robustness of the results by data
imputation in tandem with best- and worst-case sensi-
tivity analyses. In addition to looking at each time point
separately, we will also test a repeated measures
approach to analysis to try and gain insight to whether
effect sizes are changing over the course of follow-up
(ie, looking at the interaction between intervention
group and time). It is anticipated that this will be
implemented using a multilevel (mixed) model for
binomial or continuous responses as appropriate.14
These models have the added advantage that they
permit analysis of unbalanced repeated measures data,
thus avoiding exclusion of participants with incomplete
data. No additional a priori adjustment of covariates or
subgroup analysis will be performed; these issues will be
explored further in supplementary analysis as part of the
development of the statistical analysis plan for the larger
trial. No interim analyses are planned.
Qualitative analysis
Thematic analysis will be conducted using appropriate
software such as N-Vivo. A sample of transcripts will be
coded and analysed independently by two researchers
and the emerging themes discussed to ensure reliability.
While providing the researchers with an opportunity to
research women’s subjective experiences, the interviews
will also offer valuable qualitative insight to aid under-
standing of the findings generated from the RCT.15 16
Additionally, this phase will provide a window of oppor-
tunity to view women’s unique experiences of an aspect
of childbirth, which would otherwise not be known and
can facilitate improvement in practice.17
In relation to the pilot RCT, capturing qualitative data
on women’s views of the impact of perineal wound
infection on their well-being, will help to ensure that the
definitive trial captures outcome areas that are relevant
to women themselves. Likewise, it may help us to
understand any barriers to participation before
embarking on a full-scale evaluation.18
Patient involvement
Following guidance from INVOLVE,19 two patient
representatives have been recruited to assist with the
design of study materials, including the information
sheet, trial questionnaires and the qualitative interview
schedule. They are also members of the trial steering
committee (TSC).
Ethical considerations and safety committee
The PREVIEW protocol has been approved by the North
Wales Research Ethics Committee (Central and East),
reference number: 10/WNo03/16.
The conduct of the trial at each recruiting site
including confidentiality and storage of all personal and
research data will be in accordance with all applicable
research governance regulatory requirements.20e26 All
recruiting maternity units will be required to sign a clin-
ical trial agreement document detailing their commit-
ment towards complying with the relevant laws,
regulations, codes of practice and obligations to
publication.
Site-specific and Research and Development approval
is required for each recruiting unit and a Participant
Identification Centre agreement is required from the
Primary Care Trusts within the recruiting localities. The
NIHR Primary Care Trust Research Network have also
acknowledged their support for the study and have made
a significant contribution towards communicating the
study to Primary Care Trusts via individual Practice
Managers within the locality of the recruiting sites.
A TSC will be convened to provide overall supervision
of the PREVIEW Study and will adhere to the MRC’s
Guidelines for Good Clinical Practice.24 Any deviations
from the clinical trial agreement will monitored by the
TSC who will decide whether further action needs to be
considered.
An independent data monitoring ethics committee
(DMEC) will be convened for the PREVIEW Study by the
sponsor and will act as an advisory committee to the
TSC. The DMEC will be the only body involved in the
study that will have access to the comparative data. The
DMEC will consist of a minimum of three members and
will include a statistician and a clinician with expertise in
the field of perineal care. The role of the DMEC will be
to monitor trial data and make recommendations to the
TSC on whether there are any safety reasons why the trial
should not continue, including monitoring evidence for
treatment harm, for example, serious adverse events
(SAE).
The safety, rights and well-being of the trial partici-
pants are paramount. The DMEC will consider whether
any interim analysis is necessary, will consider data from
any analysis and considers requests for its release and will
then advise the TSC.
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A standardised operating procedure for the DMEC has
been developed specifically for the PREVIEW Study
based on MRC guidance, the template produced by the
DAMOCLES Study Group and the ICH Harmonised
Tripartite Guideline, for Good Clinical Practice.24e26
In accordance with NIHR Good Clinical Practice,27
safety reporting guidance for a non-clinical trial of an
investigational medicinal product including SAE has
been made available for all recruiting sites. The guid-
ance includes definitions of SAE; who the SAE should be
reported to, when and how to report the SAE and what
information will be need for the Research Ethics
Committee, a copy of the National Research Ethics
Service (NRES) SAE reporting form is also provided.
Data regarding adverse events, other unintended effects
of the trial interventions or protocol violations will be
conveyed to the DMEC as and when necessary.
DISCUSSION
This pilot RCT addresses an area of clinical research that
has been extremely neglected and has the potential of
making a significant impact on women’s health and well-
being. The evidence gained from the study will inform
a definitive RCT that will provide robust evidence of
what is the best management of perineal wound dehis-
cence and hence be used by policymakers, clinicians,
patients and the public to develop evidence-based best
practice guidelines. This will potentially lead to signifi-
cant improvements in perineal care and will help to
reduce the short- and long-term morbidity experienced
by women.
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